Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity.

J Cachexia Sarcopenia Muscle · 2025 · PMC11788588 · PMID 39825571

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Among mITT2 W0–W16 patients, high muscle mass loss ( n = 27) independently predicted OS ( p = 0.012) and showed a trend toward negatively affecting TUDD of HRQoL.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.